ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER-Reference-Cited by-同舟云学术

ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER

Published:1982-10 Issue:8303 Volume:320 Page:842-846
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cartwright RaymondA.,Rogers HowardJ.,Barham-Hall Denise,Glashan RobinW.,Ahmad RaadA.,Higgins Elizabeth,Kahn MohidA.

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. The N- and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-ammofluorene in the dog;Poirier;Cancer Res,1963

2. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities;Lower;Biochem Pharmacol,1973

3. Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other species;Lower;J Toxicol Envir Hlth,1976

4. N-acetyltransferase phenotype and the risk of urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark;Lower;Envir Hlth Perspect,1979

5. Human acetylation polymorphism;Evans;J Lab Clin Med,1964

Cited by 335 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arylamine N-Acetyltransferases;Reference Module in Biomedical Sciences;2024

2. Drug metabolism;Pharmacognosy;2024

3. Analysis of variants associated with abnormal drug responses, genetics, and genomics in drug design;Progress in Genomic Medicine;2022

4. Risk assessment for o ‐toluidine and bladder cancer incidence;American Journal of Industrial Medicine;2021-06-10

5. Case Study 10: A Case to Investigate Acetyl Transferase Kinetics;Methods in Molecular Biology;2021